Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | Yes | No |
Is net profit margin increasing? | Yes | Yes |
Is asset turnover increasing? | Yes | Yes |
Is equity multiplier increasing? | Yes | No |
Competitors Used |
---|
AstraZeneca PLC |
Novartis AG |
Merck KGaA |
Roche Holding AG |
Sanofi |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
AZN | 0QLR | 14 | 0QOK | 0O59 | GLAX.F | |||
Return On Equity | ||||||||
Latest Twelve Months | 18% | 26% | 10% | 27% | 7% | 19% | ||
Fiscal Year - 1 | 16% | 16% | 11% | 40% | 7% | 41% | ||
Fiscal Year - 2 | 9% | 10% | 14% | 47% | 11% | 35% | ||
Fiscal Year - 3 | 0% | 37% | 16% | 46% | 9% | 22% | ||
Fiscal Year - 4 | 22% | 14% | 11% | 41% | 20% | 37% | ||
Fiscal Year - 5 | 10% | 11% | 7% | 45% | 5% | 61% | ||
Average | 12% | 19% | 12% | 41% | 10% | 36% | ||
Median | 13% | 15% | 11% | 43% | 8% | 36% | ||
Benchmarks | Ticker | |||||||
AstraZeneca PLC | LSE:AZN | |||||||
Novartis AG | LSE:0QLR | |||||||
Merck KGaA | LSE:0O14 | |||||||
Roche Holding AG | LSE:0QOK | |||||||
Sanofi | LSE:0O59 |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | AZN | 0QLR | Jan-00 | 0QOK | 0O59 | GLAX.F | ||
Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
Revenues | ||||||||
Latest Twelve Months | 54,073 | 51,722 | 21,156 | 62,395 | 44,286 | 31,376 | ||
Fiscal Year | 54,073 | 51,722 | 21,156 | 62,395 | 44,286 | 31,376 | ||
Fiscal Year - 1 | 45,811 | 46,660 | 20,993 | 60,441 | 41,109 | 30,328 | ||
Fiscal Year - 2 | 44,351 | 43,461 | 22,232 | 65,814 | 40,304 | 29,324 | ||
Fiscal Year - 3 | 37,417 | 43,974 | 19,687 | 65,850 | 39,175 | 24,696 | ||
Fiscal Year - 4 | 26,617 | 49,898 | 17,534 | 60,343 | 37,369 | 24,354 | ||
Fiscal Year - 5 | 24,384 | 48,677 | 16,152 | 63,751 | 37,631 | 33,754 | ||
Net Income | ||||||||
Latest Twelve Months | 7,035 | 11,941 | 2,777 | 8,277 | 5,496 | 2,575 | ||
Fiscal Year | 7,035 | 11,941 | 2,777 | 8,277 | 5,496 | 2,575 | ||
Fiscal Year - 1 | 5,955 | 8,568 | 2,824 | 11,498 | 5,062 | 4,928 | ||
Fiscal Year - 2 | 3,288 | 6,049 | 3,326 | 12,421 | 7,970 | 4,461 | ||
Fiscal Year - 3 | 112 | 22,908 | 3,055 | 13,930 | 6,223 | 3,316 | ||
Fiscal Year - 4 | 3,196 | 8,072 | 1,987 | 14,295 | 12,294 | 4,873 | ||
Fiscal Year - 5 | 1,335 | 7,142 | 1,292 | 13,497 | 2,855 | 4,645 | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 101,119 | 99,945 | 48,495 | 90,468 | 126,464 | 59,005 | ||
Latest Fiscal Quarter | 104,035 | 102,246 | 51,567 | 101,801 | 132,798 | 59,463 | ||
Fiscal Year | 104,035 | 102,246 | 51,567 | 101,801 | 132,798 | 59,463 | ||
Fiscal Year - 1 | 101,119 | 99,945 | 48,495 | 90,468 | 126,464 | 59,005 | ||
Fiscal Year - 2 | 96,483 | 117,453 | 48,535 | 88,151 | 126,722 | 60,146 | ||
Fiscal Year - 3 | 105,363 | 131,795 | 45,362 | 92,317 | 120,242 | 79,103 | ||
Fiscal Year - 4 | 66,729 | 127,778 | 41,796 | 86,138 | 114,413 | 80,431 | ||
Fiscal Year - 5 | 61,377 | 118,370 | 43,808 | 83,091 | 112,630 | 79,692 | ||
Fiscal Year - 6 | 60,651 | 145,563 | 36,888 | 78,517 | 111,408 | 58,066 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 39,143 | 46,667 | 26,680 | 29,315 | 74,040 | 13,347 | ||
Latest Fiscal Quarter | 40,786 | 44,046 | 29,912 | 31,767 | 77,507 | 13,671 | ||
Fiscal Year | 40,786 | 44,046 | 29,912 | 31,767 | 77,507 | 13,671 | ||
Fiscal Year - 1 | 39,143 | 46,667 | 26,680 | 29,315 | 74,040 | 13,347 | ||
Fiscal Year - 2 | 37,037 | 59,342 | 25,927 | 27,992 | 74,784 | 10,598 | ||
Fiscal Year - 3 | 39,268 | 67,655 | 21,338 | 24,489 | 68,681 | 15,055 | ||
Fiscal Year - 4 | 15,622 | 56,598 | 16,946 | 36,341 | 63,106 | 14,587 | ||
Fiscal Year - 5 | 13,127 | 55,474 | 17,841 | 32,747 | 59,056 | 11,405 | ||
Fiscal Year - 6 | 12,468 | 78,614 | 17,200 | 27,622 | 58,876 | 3,781 |